Aging/Open research questions: Unterschied zwischen den Versionen
Glanz (Diskussion | Beiträge) Aging – freigegebene Erstveröffentlichung 6faa740d2c794e56888ab060b71d3212 cb714552aa09 |
Glanz (Diskussion | Beiträge) Aging daily 9d3dc6b6ab424facafd8602ef0da0575 cb714552aa09 |
||
| Zeile 1: | Zeile 1: | ||
__NOTOC__ | __NOTOC__ | ||
<div class="aging-research-world" lang="en" style="max-width:1100px;margin:0 auto;line-height:1.65;overflow-wrap:anywhere;word-wrap:break-word;"> | <div class="aging-research-world" lang="en" style="max-width:1100px;margin:0 auto;line-height:1.65;overflow-wrap:anywhere;word-wrap:break-word;"> | ||
[[Aging|← Overview]] | <div class="aging-topbar"><span>[[Aging|← Overview]]</span><div class="aging-languages" role="navigation" aria-label="Sprache / Language"><span class="aging-language" title="Deutsch">[[Altern/Offene Forschungsfragen|🇩🇪]]</span><span class="aging-language" title="English">[[Aging/Open research questions|🇬🇧]]</span></div></div> | ||
<div class="aging-note">'''Updated research direction · 2026-09-28''' | |||
The earlier synthesis has been critically refined. AG-H01 is a research framework; AG-H02 remains an unconfirmed secondary route. The new target model AG-T01 tests selective protein clearance while preserving functional synapses. [[Aging/Research reports/2026-09-28/Deep dive|Deep dive with counterevidence and decision criteria →]]</div> | |||
== Open research questions == | == Open research questions == | ||
Version vom 28. September 2026, 22:56 Uhr
Updated research direction · 2026-09-28
The earlier synthesis has been critically refined. AG-H01 is a research framework; AG-H02 remains an unconfirmed secondary route. The new target model AG-T01 tests selective protein clearance while preserving functional synapses. Deep dive with counterevidence and decision criteria →
Open research questions
Falsifiable questions with priorities and stopping criteria.
Prioritised questions
- High: Can an intervention change protein activity while preserving neuronal function? Falsification: marker change without functional benefit.
- High: Which temporally separated regeneration phases require opposing interventions? Falsification: identical effects regardless of timing and cell type.
- High: Which apparent anti-aging effects can be explained by cell-composition changes or selection?
- Medium: Do findings replicate in older animals, both sexes and independent laboratories?
- Medium: Do biomarkers predict intervention benefit or only risk?
Counterevidence applies to the specific claim under defined conditions. A non-significant difference does not establish equivalence. Priorities reflect information value, not clinical readiness. Add questions only with source context, expected information gain and bounded testing effort.
Current report with sources and evidence · Status rules
Altern / Aging research world · Updated 2026-09-28. No self-medication or personal treatment plans.